Royalty Pharma: Sandy Lamm LLC sells 25,000 shares
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Royalty Pharma plc (RPRX) EVP, Research & Investments Marshall Urist reported that Sandy Lamm LLC sold 25,000 Class A Ordinary Shares on November 16, 2026, in two transactions under a Rule 10b5-1 plan adopted August 7, 2026. The weighted-average prices were $69.4701 for 23,592 shares and $69.9941 for 1,408 shares; the disclosed transaction ranges were $68.93–$69.92 and $69.92–$70.00 per share, respectively.
The statement also lists 19,020 shares held indirectly by an IRA and 5,341 shares held directly. It says Marshall Urist and family vehicles hold limited partnership interests exchangeable into 2,294,120 Class A Ordinary Shares, and Class E Ordinary Shares exchangeable into 1,356,528 Class A Ordinary Shares; the Class E shares are subject to vesting conditions.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Class A Ordinary Shares F1, F2 | 23,592 | $69.4701 | $1.64M |
| Sale | Class A Ordinary Shares F1, F3 | 1,408 | $69.9941 | $99K |
| Holding | Class A Ordinary Shares | -- | -- | -- |
| Holding | Class A Ordinary Shares | -- | -- | -- |
Footnotes (3)
- F1. All reported transactions were effected pursuant to a 10b5-1 plan adopted by the Reporting Person on August 7, 2026.
- F2. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $68.93 to $69.92 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F3. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.92 to $70.00 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Key Figures
Key Terms
Rule 10b5-1 plan regulatory
weighted average price financial
limited partnership interests technical
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.